Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Study sponsor: COMPASS Pathways
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-11-18Actual
Enrollment · participants32Actual
Source updated2024-12-04Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.